J Physiol Society Membership
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Physiol Volume 571, Number 2, 403-413, March 1, 2006 DOI: 10.1113/jphysiol.2005.102905
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
571/2/403    most recent
jphysiol.2005.102905v1
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, X.-L.
Right arrow Articles by Pan, H.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, X.-L.
Right arrow Articles by Pan, H.-L.
Related Collections
Right arrow Neuroscience

Neuroscience

Dynamic regulation of glycinergic input to spinal dorsal horn neurones by muscarinic receptor subtypes in rats

Xiu-Li Wang1,2, Hong-Mei Zhang1, De-Pei Li1, Shao-Rui Chen1 and Hui-Lin Pan1

1 Department of Anesthesiology, Department of Neural and Behavioral Sciences, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA
2 Department of Anesthesiology, The Third Hospital of HeBei Medical University, Shijiazhuang 050051, China

Activation of spinal muscarinic acetylcholine receptors (mAChRs) inhibits nociception. However, the cellular mechanisms of this action are not fully known. In this study, we determined the role of mAChR subtypes in regulation of synaptic glycine release in the spinal cord. Whole-cell voltage-clamp recordings were performed on lamina II neurones in the rat spinal cord slices. The mAChR agonist oxotremorine-M significantly increased the frequency of glycinergic sIPSCs but not mIPSCs. Surprisingly, the effect of oxotremorine-M on sIPSCs was largely attenuated at a higher concentration. On the other hand, 1–10 µM oxotremorine-M dose-dependently increased the frequency of sIPSCs in rats pretreated with intrathecal pertussis toxin. Furthermore, oxotremorine-M also dose-dependently increased the frequency of sIPSCs in the presence of himbacine (an M2/M4 mAChR antagonist) or AF-DX116 (an M2 mAChR antagonist). The M3 mAChR antagonist 4-DAMP abolished the stimulatory effect of oxotremorine-M on sIPSCs. Interestingly, the GABAB receptor antagonist CGP55845 potentiated the stimulatory effect of oxotremorine-M on sIPSCs. In the presence of CGP55845, both himbacine and AF-DX116 similarly reduced the potentiating effect of oxotremorine-M on sIPSCs. Collectively, these data suggest that the M3 subtype is present on the somatodendritic site of glycinergic neurones and is mainly responsible for muscarinic potentiation of glycinergic input to spinal dorsal horn neurones. Concurrent stimulation of mAChRs on adjacent GABAergic interneurones attenuates synaptic glycine release through presynaptic GABAB receptors on glycinergic interneurones. This study illustrates a complex dynamic interaction between GABAergic and glycinergic synapses in the spinal cord dorsal horn.

(Received 2 December 2005; accepted after revision 11 January 2006; first published online 12 January 2006)
Corresponding author H.-L. Pan: Department of Anesthesiology and Pain Medicine, University of Texas, M.D. Anderson Cancer Center, Unit 409, 1400 Holcombe Blvd, Houston, TX77030, USA. Email: hpan{at}psu.edu




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H.-Y. Zhou, H.-M. Zhang, S.-R. Chen, and H.-L. Pan
Increased C-Fiber Nociceptive Input Potentiates Inhibitory Glycinergic Transmission in the Spinal Dorsal Horn
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1000 - 1010.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H.-M. Zhang, H.-Y. Zhou, S.-R. Chen, D. Gautam, J. Wess, and H.-L. Pan
Control of Glycinergic Input to Spinal Dorsal Horn Neurons by Distinct Muscarinic Receptor Subtypes Revealed Using Knockout Mice
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 963 - 971.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. R. Sullivan, L. Leventhal, J. Harrison, V. A. Smith, T. A. Cummons, T. B. Spangler, S.-C. Sun, P. Lu, A. J. Uveges, B. W. Strassle, et al.
Pharmacological Characterization of the Muscarinic Agonist (3R,4R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-aza-bicyclo[2.2.1]heptane (WAY-132983) in in Vitro and in Vivo Models of Chronic Pain
J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1294 - 1304.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
X.-L. Wang, H.-M. Zhang, S.-R. Chen, and H.-L. Pan
Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy
J. Physiol., March 15, 2007; 579(3): 849 - 861.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H.-M. Zhang, S.-R. Chen, and H.-L. Pan
Regulation of Glutamate Release From Primary Afferents and Interneurons in the Spinal Cord by Muscarinic Receptor Subtypes
J Neurophysiol, January 1, 2007; 97(1): 102 - 109.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 The Physiological Society.